In Oct. 1952, Dr. William McDowall Hammon of the University of Pittsburgh Graduate School of Public Health published results that provided the first evidence that antibodies to polio could prevent disease.

Hammon led the first major breakthrough in prevention of the disease by using passive immunization in one of the earliest double-blind, placebo-controlled clinical trials. This study provided the first evidence that antibodies to poliovirus could prevent the disease in humans.